Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Francesca Bruce

Francesca Bruce has been writing news and analysis about all things affecting the pharmaceutical industry since 2008. She has paid special attention to policy and regulatory developments but particularly likes to write about market access and how medicines may  - or may not  -  make it to patients. She generally writes about Europe, but really enjoys uncovering news from further corners of the globe, especially Latin America and the Middle East.

Latest From Francesca Bruce

WHO Launches Action Plan For Cross-Country Market Access Collaborations

While information sharing is key to cross-country collaborations on access to medicines and can lead to major benefits, it is hard to sell to political leaders and the media, says a report from the World Health Organization’s regional office for Europe.

Europe Legal Issues

EU Orphan Law Under Attack Over ‘Flawed Incentives’

The European Commission says it will publish its review of the EU orphan drug legislation in the coming days.

Europe Legislation

UK Pulls Out Of Unified Patent Court Agreement

The UK has formally withdrawn its ratification of the Unified Patent Court Agreement, adding to the uncertainty over its future.

Intellectual Property United Kingdom

Brazil Issues Guidance For Clinical Trials Conducted During Pandemic

Brazil’s medicines regulator has published advice for developers on how to proceed with ongoing clinical trials and bioequivalence studies during the current COVID-19 pandemic.

Opaque Pricing Could Protect Europe From US Policy

Obscure drug pricing in Europe could help minimize an “access threat” posed by US pricing policies.

Europe North America

England’s NICE To Help Colombia Boost Access To Medicines

The agreement should help Colombia improve its HTA process and access to medicines there.

Europe United Kingdom
See All
UsernamePublicRestriction

Register